Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of a Novel CCH Protocol for Peyronie's Disease Among Prior Non-responders
NCT05108558Phase 4Completed
- Sponsor
- Charitable Union for the Research and Education of Peyronie's Disease
- Start
- Sep 2021
- Primary completion
- Jun 2026
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Charitable Union for the Research and Education of Peyronie's Disease. Started Sep 2021; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT05108558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05108558.